Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 17.12 USD 1.12% Market Closed
Market Cap: 409m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

Cartesian Therapeutics Inc
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cartesian Therapeutics Inc
Depreciation & Amortization Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
Cartesian Therapeutics Inc
NASDAQ:RNAC
Depreciation & Amortization
$937k
CAGR 3-Years
-5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Depreciation & Amortization
$8.4B
CAGR 3-Years
-1%
CAGR 5-Years
34%
CAGR 10-Years
27%
Gilead Sciences Inc
NASDAQ:GILD
Depreciation & Amortization
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Depreciation & Amortization
$5.6B
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
11%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Depreciation & Amortization
$208.6m
CAGR 3-Years
20%
CAGR 5-Years
16%
CAGR 10-Years
12%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Depreciation & Amortization
$469.5m
CAGR 3-Years
20%
CAGR 5-Years
19%
CAGR 10-Years
25%

See Also

What is Cartesian Therapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
937k USD

Based on the financial report for Sep 30, 2024, Cartesian Therapeutics Inc's Depreciation & Amortization amounts to 937k USD.

What is Cartesian Therapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
6%

Over the last year, the Depreciation & Amortization growth was 15%. The average annual Depreciation & Amortization growth rates for Cartesian Therapeutics Inc have been -5% over the past three years , 6% over the past five years .

Back to Top